HKBU develops dual-targeting drug for EBV-related cancers
HONG KONG, March 2021 /PRNewswire/ -- A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to ...
Read more
HONG KONG, March 2021 /PRNewswire/ -- A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to ...
Read more